RxDoctor Payments DataLook up a doctor →

Divyansu Patel, MD

Psychiatry · Austin, TXNPI 1710178702

Payments from drug & device makers

$2,841,246in general payments, 2019–2025

Across 1,973 payments — averaging $1440.06 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$777K
  • Janssen Research & Development, LLC$562K
  • Sage Therapeutics, LLC$500K
  • Genentech, Inc.$285K
  • Supernus Pharmaceuticals, Inc.$281K
  • ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$151K
  • plus $285K from 44 others
$96,275in research payments, 2019–2025

Across 36 payments — averaging $2674.30 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Arbor Pharmaceuticals, Inc.$92K
  • Supernus Pharmaceuticals, Inc.$3K
  • Neos Therapeutics, LP$1K

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
AbbVie(2 entities)271$777,258
Janssen Research & Development, LLC93$562,247
Sage Therapeutics, LLC119$500,056
Genentech, Inc.19$285,395
Supernus Pharmaceuticals, Inc.201$280,937
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)86$150,651
Teva Pharmaceuticals USA, Inc.120$96,983
Otsuka Pharmaceutical Development & Commercialization, Inc.10$68,634
Biohaven Pharmaceutical Holding Company Ltd.4$29,551
Sunovion Pharmaceuticals Inc.2$26,817
Otsuka America Pharmaceutical, Inc.203$14,724
Pfizer6$12,918
Ironshore Pharmaceuticals Inc.99$11,972
Johnson & Johnson56$4,478
Shire North American Group Inc11$4,060
Alkermes, Inc.115$2,136
Neos Therapeutics, LP68$1,720
Tris Pharma Inc71$1,408
E.r. Squibb & Sons, L.L.C.2$1,229
Lundbeck LLC72$1,027
Takeda Pharmaceuticals U.S.A., Inc.57$917
Axsome Therapeutics, Inc.28$753
Neurocrine Biosciences, Inc.22$715
Corium, LLC36$685
Eisai Inc.22$559
Arbor Pharmaceuticals, Inc.36$482
Bausch Health US, LLC21$410
Janssen Scientific Affairs, LLC4$367
Avanir Pharmaceuticals, Inc.11$289
Vanda Pharmaceuticals Inc.18$265
Jazz Pharmaceuticals Inc.16$249
Idorsia Pharmaceuticals US Inc19$231
Adlon Therapeutics L.p.12$183
Vertical Pharmaceuticals, LLC9$177
Medtronic1$122
Noven Therapeutics, LLC5$106
CSL Behring4$89
Biocryst US Sales Co., LLC4$59
Merck4$49
Collegium Pharmaceutical, Inc.2$46
Livanova USA, Inc.2$46
Boehringer Ingelheim1$40
Kaleo, Inc.2$36
Alfasigma USA, Inc.2$35
Sumitomo Pharma America, Inc.1$32
OWP Pharmaceuticals, Inc.2$30
Azurity Pharmaceuticals, Inc.1$25
Rhodes Pharmaceuticals L.p.1$17
Neuronetics, Inc.1$17
Regeneron Healthcare Solutions, Inc.1$15

How this compares

$2,841,246 in reported general payments places this provider in the 95th percentile of 2,238 psychiatry providers in Texas.

See all psychiatry providers in Texas

Medicare billing

Part B allowed, 2024
$20,638
Medicare patients
47
Services billed
218

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other psychiatry in Austin

See the full list for Texas

Where these figures come from

Is this you, or does something look wrong? →